MSGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Madison Square Garden Sports Corp (MSGS) is not an ideal buy for a beginner investor with a long-term strategy at this moment. While the stock has shown strong growth over the past year and analysts have raised price targets, the financial performance is weak with declining revenue and net losses. Additionally, technical indicators do not suggest a strong entry point, and there are no significant trading signals or catalysts to justify immediate action.
The MACD is negatively expanding (-2.297), indicating bearish momentum. RSI is neutral at 41.004, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level (281.842) at 278.2 in pre-market, with key support at 269.08 and resistance at 294.605.
Analysts have raised price targets, with JPMorgan and Susquehanna maintaining positive ratings.
Reinhart Partners' acquisition of 214,891 shares shows institutional confidence.
MSGS shares have risen 34.3% over the past year, reflecting investor optimism.
Financial performance is weak, with a 25.99% YoY revenue drop and continued net losses.
Wolfe Research downgraded the stock, citing minimal catalysts for further upside.
Technical indicators show no clear bullish momentum.
In Q1 2026, revenue dropped by 25.99% YoY to $39.45 million. Net income improved slightly but remains negative at -$8.81 million. EPS increased to -0.37, up 19.35% YoY. Gross margin dropped to 80.28%, down 6.20% YoY.
Analyst sentiment is mixed but leans positive. Recent upgrades include JPMorgan raising the price target to $305 and Susquehanna to $356, both maintaining positive ratings. However, Wolfe Research downgraded the stock, citing limited catalysts for further growth.
